Data Sciences International, a subsidiary of Harvard Bioscience is spotlighting a range of its products and applications for preclinical life science research at SOT 2019, the 58th Annual Meeting of the Society of Toxicology and ToxExpo in Baltimore on March 10-14. DSI’s products are at the forefront of innovation and provide an impressive range of resources for researchers involved in toxicological studies,” said Jeffrey Duchemin, President and CEO of Harvard Bioscience. “Demonstrating our latest innovations at SOT, as well as participating in presentations, are excellent ways for us to interact with customers and communicate the broad scope and potential of our instrumentation to members of the scientific community.” DSI will be sponsoring a session titled “Novel Approaches for Respiratory Measurement in Safety Pharmacology and Toxicology” on Tuesday, March 12 from 4:30-5:30 PM in Room 339 at the Baltimore Convention Center. During the session, Dr. Brian Roche from Charles River Laboratories and Dr. Benjamin Wong from the United States Army Medical Research Institute of Chemical Defense will discuss how DSI solutions assist in achieving study goals for safety pharmacology and the development of medical countermeasures for chemical agent exposure.
https://thefly.com/landingPageNews.php?id=2870823
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.